- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/04 - Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
Patent holdings for IPC class C07D 231/04
Total number of patents in this class: 61
10-year publication summary
|
3
|
3
|
7
|
2
|
4
|
5
|
5
|
5
|
3
|
4
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21113 |
5 |
| The General Hospital Corporation | 4809 |
4 |
| The Broad Institute, Inc. | 1927 |
4 |
| Massachusetts Institute of Technology | 10196 |
3 |
| The Feinstein Institute for Medical Research | 248 |
3 |
| Synthis Therapeutics, Inc. | 13 |
3 |
| FUJIFILM Corporation | 30244 |
2 |
| Council of Scientific & Industrial Research | 1431 |
2 |
| FMC Corporation | 812 |
2 |
| National Institute of Biological Sciences, Beijing | 100 |
2 |
| Neuropro Therapeutics, Inc. | 22 |
2 |
| Tokyo Ohka Kogyo Co., Ltd. | 1547 |
2 |
| Psy Therapeutics, Inc. | 15 |
2 |
| Janssen Pharmaceutica N.V. | 3233 |
1 |
| Centre National de La Recherche Scientifique | 10865 |
1 |
| Bayer AG | 3435 |
1 |
| The Board of Trustees of the Leland Stanford Junior University | 6594 |
1 |
| The Regents of the University of Michigan | 4903 |
1 |
| The Trustees of the University of Pennsylvania | 4403 |
1 |
| Argusina, Inc. | 2 |
1 |
| Other owners | 18 |